Case number 2:23-cv-01902
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 29, 2023 | 19 | TEXT ORDER: The initial scheduling conference previously scheduled for October 2, 2023 (ECF No. 16 ) is canceled. So Ordered by Magistrate Judge Edward S. Kiel on 9/29/2023. (sms) (Entered: 09/29/2023) (0) |
| Sep 28, 2023 | 18 | CONSENT JUDGMENT enjoining Alembic, including any of its affiliates, successors and assigns, unless otherwise specifically authorized by Actelion, from infringing the Licensed Patent, on its own part or through any Affiliate, by making, having made, using, selling, offering to sell, importing or distributing of the Alembic Product; dismissing all claims, counterclaims, affirmative defenses and demands in this action with prejudice; directing the Clerk of the Court to CLOSE this matter. Signed by Judge Stanley R. Chesler on 9/28/2023. (dam) (Entered: 09/28/2023) (4) |
| Sep 26, 2023 | 17 | Letter from Keith J. Miller, Esq, to Hon. Stanley R. Chesler re Proposed Consent Judgment. (Attachments: # 1 Text of Proposed Order)(MILLER, KEITH) (Entered: 09/26/2023) (0) |
| Aug 31, 2023 | 16 | LETTER ORDER: A telephonic initial scheduling conference shall be held on October 2, 2023 at 9:45 a.m. before Magistrate Judge Edward S. Kiel. The dial in number is 1-888-684-8852 and the access code is 310-0383#. The parties shall file a proposed joint discovery plan no later than three business days before the scheduled initial conference. The Court's form joint discovery plan can be found here. Signed by Magistrate Judge Edward S. Kiel on 8/31/2023. (sms) (Entered: 08/31/2023) (2) |
| Aug 29, 2023 | 15 | NOTICE of Appearance by DENNIES VARUGHESE on behalf of ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS, INC. (VARUGHESE, DENNIES) (Entered: 08/29/2023) (2) |
| Aug 28, 2023 | 13 | ANSWER to Complaint by ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS, INC..(VARUGHESE, DENNIES) (Entered: 08/28/2023) (16) |
| Aug 28, 2023 | 14 | Corporate Disclosure Statement by ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS, INC. identifying Alembic as Corporate Parent.. (VARUGHESE, DENNIES) (Entered: 08/28/2023) (1) |
| Aug 15, 2023 | 12 | STIPULATION AND ORDER granting the parties' 11 request that the time for Defendants to answer, move, or otherwise respond to the Complaint be extended to 8/28/2023. Signed by Magistrate Judge Edward S. Kiel on 8/15/2023. (mxw) (Entered: 08/15/2023) (2) |
| Aug 14, 2023 | 11 | Letter from Keith J. Miller, Esq. to Hon. Edward S. Kiel, U.S.M.J. re Proposed Stipulation and Order Extending Time. (Attachments: # 1 Text of Proposed Order)(MILLER, KEITH) (Entered: 08/14/2023) (0) |
| Jul 12, 2023 | 9 | Letter from Keith J. Miller, Esq. to Hon. Edward S. Kiel, U.S.M.J. re Proposed Stipulation and Order Extending Time. (Attachments: # 1 Text of Proposed Order)(MILLER, KEITH) (Entered: 07/12/2023) (0) |
| Jul 12, 2023 | 10 | STIPULATION and ORDER extending the time for the Defendants to Answer or otherwise respond to the Complaint for an additional thirty (30) days through 8/14/2023. Signed by Magistrate Judge Edward S. Kiel on 7/12/2023. (dam) (Entered: 07/12/2023) (2) |
| Jun 14, 2023 | 8 | STIPULATION and ORDER extending the time for Defendants Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. to answer or otherwise respond to the Complaint for thirty (30) days, until 7/13/2023. Signed by Magistrate Judge Edward S. Kiel on 6/14/2023. (dam) (Entered: 06/14/2023) (2) |
| Jun 13, 2023 | 7 | Letter from Keith J. Miller, Esq. to Hon. Edward S. Kiel, U.S.M.J. re Proposed Stipulation and Order Extending Time. (Attachments: # 1 Text of Proposed Order)(MILLER, KEITH) (Entered: 06/13/2023) (0) |
| Apr 26, 2023 | 5 | WAIVER OF SERVICE Returned Executed by ACTELION PHARMACEUTICALS US, INC., ACTELION PHARMACEUTICALS LTD. ALEMBIC PHARMACEUTICALS, INC. waiver sent on 4/14/2023, answer due 6/13/2023. (MILLER, KEITH) (Entered: 04/26/2023) (1) |
| Apr 26, 2023 | 6 | WAIVER OF SERVICE Returned Executed by ACTELION PHARMACEUTICALS US, INC., ACTELION PHARMACEUTICALS LTD. ALEMBIC PHARMACEUTICALS LIMITED waiver sent on 4/14/2023, answer due 6/13/2023. (MILLER, KEITH) (Entered: 04/26/2023) (1) |
| Apr 12, 2023 | 3 | AO120 Patent Form filed. (Attachments: # 1 Complaint) (lag, ) (Entered: 04/12/2023) (0) |
| Apr 12, 2023 | 4 | SUMMONS ISSUED as to ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (lag, ) (Entered: 04/12/2023) (2) |
| Apr 5, 2023 | N/A | Case assigned to Judge Stanley R. Chesler and Magistrate Judge Edward S. Kiel. (jr) (Entered: 04/05/2023) (0) |
| Apr 4, 2023 | 1 | COMPLAINT against ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14223126) , Related Case Selected, filed by ACTELION PHARMACEUTICALS US, INC., ACTELION PHARMACEUTICALS LTD. (Attachments: # 1 Exhibit A to Complaint, # 2 Civil Cover Sheet)(MILLER, KEITH) (Entered: 04/04/2023) (0) |
| Apr 4, 2023 | 2 | Corporate Disclosure Statement by ACTELION PHARMACEUTICALS LTD, ACTELION PHARMACEUTICALS US, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH) (Entered: 04/04/2023) (2) |
